7106 POSTER DISCUSSION The Proteasome-inhibitor Bortezomib is Active in Human Urothelial Cancer Cell Lines in Combination With the Tyrosine-kinase Inhibitor Sunitinib or Cisplatinum

✍ Scribed by Voql, U.M.; Berger, W.; Bojic, M.; Lamm, W.; Haitel, A.; Kramer, G.; Zielinski, C.C.; Schmidinger, M.

• Book ID: 122837348
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 43 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)72021-4